drugset / Trial / NCT02407119

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

NCT02407119

Phase 3 Active not recruiting 470 enrolled National Cancer Center, Korea
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study evaluates whether Helicobacter pylori eradication improves precancerous lesions including glandular atrophy and intestinal metaplasia as well as metachronous cancers or dysplasias after endoscopic mucosal resection for gastric cancer.

Timeline

Start
2003-06
Primary completion
2016-06
Completion
2030-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 1000 mg
Comparator Clarithromycin Small molecule 500 mg
Comparator Omeprazole Other / unclassified 20 mg
Comparator Rabeprazole Small molecule 10 mg